Torben Nissen
Director Ejecutivo en Repertoire Immune Medicines, Inc. .
Fortuna: - $ al 31/12/2023
Perfil
Torben Straight Lauesgaard Nissen is currently the Chief Executive Officer at Repertoire Immune Medicines, Inc. and an Executive Partner at Flagship Pioneering.
Previously, he held positions such as Managing Director at Maxygen, Inc., Chief Operating Officer & Executive Director at Centers for Therapeutic Innovation, Independent Director at Axcella Health, Inc., Director at Ring Therapeutics, Inc., Head-Worldwide Research & Development at Pfizer Inc., Principal at Novo Nordisk A, President at moksha8 Pharmaceuticals, Inc., Chief Operating Officer at Ascendis Pharma A, and President at Rubius Therapeutics, Inc. He has a graduate and doctorate degree from the Technical University of Denmark.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AXCELLA HEALTH, INC.
-.--% | 31/10/2023 | 0 ( -.--% ) | - $ | 31/12/2023 |
Cargos activos de Torben Nissen
| Empresas | Cargo | Inicio |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Inversor de Capital Privado | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Director Ejecutivo | 06/11/2022 |
Antiguos cargos conocidos de Torben Nissen.
| Empresas | Cargo | Fin |
|---|---|---|
| AXCA HEALPAR | Director/Miembro de la Junta | 01/11/2023 |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 01/12/2021 |
| RUBIUS THERAPEUTICS | Presidente | 24/07/2019 |
| PFIZER, INC. | Corporate Officer/Principal | 01/11/2016 |
| Centers for Therapeutic Innovation | Director de Operaciones | 01/01/2014 |
Formación de Torben Nissen.
| Technical University of Denmark | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| AXCA HEALPAR | Health Technology |
| Empresas privadas | 7 |
|---|---|
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Centers for Therapeutic Innovation | |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Torben Nissen
